Inventor

Luc Montagnier

Inventor
Le Plessis Robinson, FR

Overview

122→
Patents
1981–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 122 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes18%
C07KPeptides16%
A61KPreparations for medical, dental or toiletry purposes15%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
Y02ATechnologies for adaptation to climate change2%
G01RMeasuring electric variables1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
11,035,011Detection of DNA sequences as risk factors for HIV infection202110,564,118Highly sensitive method for detection of viral HIV DNA remaining after antiretroviral therapy of AIDS patients202010,525,066System and method for the detection and treatment of infection by a microbial agent associated with HIV infection202010,227,665Detection of DNA sequences as risk factors for HIV infection201910,039,777Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders20189,910,013'System and method for the analysis of DNA sequences'20189,580,758'System and method for the detection and treatment of infection by a microbial agent associated with HIV infection'20179,547,029'System and method for the analysis of DNA sequences'20179,316,610'System and method for the analysis of DNA sequences in biological fluids'20169,133,525'Detection of DNA sequences as risk factors for HIV infection'20159,029,165'System and method for the analysis of DNA sequences in biological fluids'20158,736,250'System and method for the analysis of DNA sequences in biological fluids'20148,507,196'Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1'20138,405,379'System and method for the analysis of DNA sequences in biological fluids'20138,329,396'Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV)'20128,236,324'Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens'20127,777,020'Nucleotide sequences derived from the env gene of HIV-1'20107,767,800'Nucleic acids obtained from LAVMAL, a variant African AIDS virus'20107,759,477'HIV-1, HIV-2, and SIV pol nucleotide fragments'20107,626,013'HIV-1 DNA fragments that hybridize to genomic HIV-1DNA'20097,585,619'Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity'20097,507,417'Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation'20097,341,731'HIV-2 antigen compositions'20087,309,589'Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing'20077,232,654'DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)'20077,217,508'Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1)'20077,205,102'Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA'20077,157,225'Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens'20077,122,188'Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1'20067,115,363'Retrovirus capable of causing AIDS, means and methods for detecting it in vitro'20067,078,516'NUCLEOTIDE SEQUENCES DERIVED FROM THE GENOME OF RETROVIRUSES OF THE HIV-1, HIV-2 AND SIV TYPE, AND THEIR USES IN PARTICULAR FOR THE AMPLIFICATION OF THE GENOMES OF THESE RETROVIRUSES AND FOR THE IN VITRO DIAGNOSIS OF THE DISEASES DUE TO THESE VIRUSES'20067,029,679'Variant of LAV viruses'20067,022,814'Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses'20066,984,721'Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80'20066,979,535'Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays'20056,951,648'Variant of LAV viruses'20056,730,304'Variant of LAV viruses'20046,664,041'Method for preparing a viral extract containing HIV-II RNA'20036,635,752'Variant of LAV viruses'20036,627,395'Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1)'20036,608,179'Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)'20036,600,023'Antibody directed against HIV-1 P25 antigen'20036,544,728'Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2'20036,518,015'Peptide comprising the sequence CAFRQVC and methods using it'20036,514,691'Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2'20036,429,306'Nucleic acids of a human immunodeficiency virus type 2 (HIV-2)'20026,428,952'Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies'20026,426,073'Variant of LAV viruses'20026,399,294'Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens'20026,395,495'Methods and kits for detecting antibodies against an HIV variant'20026,355,789'CLONED DNA SEQUENCES RELATED TO THE ENTIRE GENOMIC RNA OF HUMAN IMMUNODEFICIENCY VIRUS II (HIV-2), POLYPEPTIDES ENCODED BY THESE DNA SEQUENCES AND USE OF THESE DNA CLONES AND POLYPEPTIDES IN DIAGNOSTIC KITS'20026,337,179'Methods and kits for detecting antibodies against an HIV variant'20026,322,964'Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies'20016,316,183'Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)'20016,296,807'Kits for the detection of human immunodeficiency virus type 2 (HIV-2) antigens'20016,284,454'Variant of LAV viruses'20016,265,149'In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies'20016,261,762'Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits'20016,261,571'Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins'20016,197,496'Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80'20016,194,142'Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses'20016,162,439'Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of producing them'20006,056,963'Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins'20006,054,565'Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2'20006,048,685'In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies'20006,037,165'Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby'20005,976,785'Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2'19995,889,158'Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens'19995,869,631'Variant of LAV viruses'19995,866,319'Methods, kits, and probes for diagnosing HIV-2'19995,858,651'Nucleotide sequences of human immunodeficiency virus type 2 (HIV-2), probes of HIV-2, and methods of using these probes'19995,843,638'Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).'19985,830,641'In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies'19985,824,482'Purification, cloning, and characterization of a novel human immunodeficiency virus LAV.sub.MAL'19985,807,992'HIV-2 transmembrane glycoprotein homodimer (gp 80)'19985,795,577'Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.'19985,786,177'Nucleotide sequences derived from the genome or retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses'19985,773,602'DNA fragments obtained from a novel human immunodeficiency virus designated LAV.sub.MAL'19985,770,703'Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene'19985,747,242'Diagnostic kits and methods for detecting antibodies to LAV viruses'19985,698,392'Nucleic acid fragments and diagnostic reagents derived from the HHV6/SIE genome and procedures for diagnosing HHV6 infections'19975,688,637'Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the disease due to these viruses'19975,688,646'Mycoplasmas-agents for detecting and characterizing mycoplasmas in vitro'19975,677,123'Mycoplasmas--agents for detecting and characterizing mycoplasmas in vitro'19975,672,689'Non-cleavable GP160 glycoproteins of HIV'19975,610,035'Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies'19975,597,896'Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes'19975,580,739'Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2'19965,578,715'Methods, kits, and probes for diagnosing HIV-2'19965,550,052'Hybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cells'19965,545,726'Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits'19965,545,520'Nucleic acid fragments and diagnostic reagents derived from the HHV6/SIE genome and procedures for diagnosing HHV6 infections'19965,514,542'Methods for propagating retrovirus for use in antibody assays'19965,470,702'HIV-2 transmembrane glycoprotein homodimer (gp 80)'19955,407,811'Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies'19955,374,519'Oligopeptides comprising p18 protein of human immunodeficiency virus (HIV), compositions comprising peptides of p18 protein of HIV, and diagnostic kits and methods for detecting acquired immune deficiency syndrome (AIDS)'19945,364,933'Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)'19945,358,937'Glycosyl phospholipid derivatives of nucleosides and their use as medicines'19945,312,902'Dimer of the precursor of HIV-2 envelope glycoprotein'19945,310,651'DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2'19945,306,614'Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2)'19945,268,265'Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV'19935,221,610'Diagnostic method and composition for early detection of HIV infection'19935,217,861'Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor'19935,208,321'HIV-2 transmembrane glycoprotein homodimer (GP 80)'19935,173,400'Antibody detection of antibodies to viral proteins in serum'19925,169,763'Viral vector coding glycoprotein of HIV-1'19925,135,864'Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor'19925,079,342'Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits'19925,066,782'Retrovirus capable of causing AIDS, means and method for detecting it in vitro'19915,055,391'Method and kit or detecting antibodies to antigens of Human Immunodeficiency Virus type 2 (HIV-2)'19915,051,496'Peptides related to human immunodeficiency virus II (HIV-2)'19915,034,511'Variant of LAV viruses'19915,030,714'Variant of LAV viruses'19915,030,718'Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes'19914,839,288'Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes'19894,798,797'Retrovirus associated with lymphadenopathies and adapted to continuous lines of lymphoblastoid B cells, capable of producing retrovirus continuously and process for their production'19894,759,929'Novel treatment'19884,708,818'Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor'19874,444,776'Dipyrido (4,3-B) (3,4-F) indoles, process for obtaining them, therapeutical use and pharmaceutical compositions'19844,434,290'Pyrido (4,3-B) carbazoles substituted in the 1 position by a polyamine chain'19844,266,060'Dipyrido [4,3-b] [3,4-f] indoles and process for obtaining them'1981

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1981–2013Based in Le Plessis Robinson, FR· patent location history
1987–2013Patents assigned to PASTEUR INSTITUT (98)· patent assignee history
1987–2007Patents assigned to US HEALTH (9)· patent assignee history
1991–2005Based in Le Plessy Robinson, FR· patent location history
1993–2013Patents assigned to CENTRE NAT RECH SCIENT (10)· patent assignee history
1993–2010Patents assigned to INST NAT SANTE RECH MED (7)· patent assignee history
1994Based in Le Plessis-Robi, FR· patent location history
1999–2021Based in Le Plessis, FR· patent location history
2007–2020Based in New York, NY, US· patent location history
2012–2021Patents assigned to MONTAGNIER LUC (16)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PASTEUR INSTITUT981987–2013
MONTAGNIER LUCself162012–2021
CENTRE NAT RECH SCIENT101993–2013
US HEALTH91987–2007
INST NAT SANTE RECH MED71993–2010
Locations
LocationPatentsSpan
Le Plessis Robinson, FR981981–2013
New York, New York, US112007–2020
Le Plessy Robinson, FR81991–2005
Le Plessis, FR41999–2021
Le Plessis-Robi, FR11994